- Home
- MESA vs ESLA Comparison
MESA vs ESLA Comparison
Compare MESA & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- ESLA
- Stock Information
- Founded
- MESA 1982
- ESLA 2021
- Country
- MESA United States
- ESLA United States
- Employees
- MESA N/A
- ESLA N/A
- Industry
- MESA Air Freight/Delivery Services
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MESA Consumer Discretionary
- ESLA Health Care
- Exchange
- MESA Nasdaq
- ESLA Nasdaq
- Market Cap
- MESA 59.5M
- ESLA 48.9M
- IPO Year
- MESA 2018
- ESLA N/A
- Fundamental
- Price
- MESA $1.45
- ESLA $2.42
- Analyst Decision
- MESA
- ESLA Strong Buy
- Analyst Count
- MESA 0
- ESLA 1
- Target Price
- MESA N/A
- ESLA $16.00
- AVG Volume (30 Days)
- MESA 130.9K
- ESLA 364.9K
- Earning Date
- MESA 11-13-2025
- ESLA 11-20-2025
- Dividend Yield
- MESA N/A
- ESLA N/A
- EPS Growth
- MESA N/A
- ESLA N/A
- EPS
- MESA N/A
- ESLA N/A
- Revenue
- MESA $406,021,000.00
- ESLA N/A
- Revenue This Year
- MESA $39.81
- ESLA N/A
- Revenue Next Year
- MESA N/A
- ESLA N/A
- P/E Ratio
- MESA N/A
- ESLA N/A
- Revenue Growth
- MESA N/A
- ESLA N/A
- 52 Week Low
- MESA $0.68
- ESLA $0.63
- 52 Week High
- MESA $1.50
- ESLA $2.55
- Technical
- Relative Strength Index (RSI)
- MESA 61.28
- ESLA 80.18
- Support Level
- MESA $1.38
- ESLA $1.52
- Resistance Level
- MESA $1.48
- ESLA $2.55
- Average True Range (ATR)
- MESA 0.07
- ESLA 0.28
- MACD
- MESA 0.00
- ESLA 0.09
- Stochastic Oscillator
- MESA 77.27
- ESLA 91.05
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.